Minerva Neurosciences | NERV - Ebitda





Ebitda Changement Date
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Adma Biologics USD 61.07M 12.52M 2026-03
ALKERMES USD 80.26M 20.05M 2026-03
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
AstraZeneca USD 5.67B 1.29B 2026-03
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Cipla INR 14.03B 4.48B 2026-06
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -9.02M 1.12M 2026-03
CSL USD 3.13B 1.17B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
J&J USD 8.27B 1.08B 2026-03
Merck USD 6.3B 2.09B 2025-12
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 5.99B 5.23B 2026-03
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.31B 3.65B 2026-03
Takeda JPY 150.25B 297.88B 2026-03
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12